Journals / Infectious diseases and clinical microbiology (Online) / 2022 / Cilt: 4 - Sayı: 2

Nasopharyngeal Carriage and Serotype Distribution of Streptococcus pneumoniae in Elderly: A Cross-sectional Study in Turkey

Pages
99–106
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The monitoring of pneumococcal serotypes can offer useful information about the circulation of this pathogen among older people and the potential protective effect of pneumococcal vaccines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The incidence and mortality of invasive pneumococcal disease are much higher in people over 65 years compared to the general population.
📊
Key Findings & Data:In this study, we aimed to determine the pneumococcal carriage prevalence and serotype distribution in adults aged ≥ 65 years living in a nursing home.
💡
Conclusion & Impact:The monitoring of pneumococcal serotypes can offer useful information about the circulation of this pathogen among older people and the potential protective effect of pneumococcal vaccines.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The incidence and mortality of invasive pneumococcal disease are much higher in people over 65 years compared to the general population. The incidence of the disease and the distribution of serotypes changed with the spread of childhood conjugate pneumococcal vaccines and the use of vaccines in the adult age group. Nasopharyngeal carriage is an important stage in the disease pathogenesis. In this study, we aimed to determine the pneumococcal carriage prevalence and serotype distribution in adults aged ≥ 65 years living in a nursing home. Materials and Methods: The nasopharyngeal swabs were taken from ≥ 65 years old people living in Narlıdere Nursing Home. The specimens were cultured and pneumococci were isolated according to colony appearance, optochin sensitivity and solubility in bile salts. Pneumococcal serotypes were identified using the capsule swelling reaction. Results: Pneumococcus was isolated in 10 of 341 subjects and the pneumococcal carriage prevalence was 2.9%. Advanced age, immunocompromised status and chronic renal failure were associated with pneumococcal carriage. In multivariate model, having immunocompromised status was significantly associated with carriage. Serotypes/serogroups of pneumococci were 7F, 23F, 10, 11, 15. 17, 20 and 33. The 13 valent conjugated pneumococcal vaccine serotype carriage prevalence was 0.6%. Conclusion: Although pneumococcal colonization in older people is uncommon, most of the isolated serotypes are not PCV13 serotypes. The monitoring of pneumococcal serotypes can offer useful information about the circulation of this pathogen among older people and the potential protective effect of pneumococcal vaccines.

🔖

Cite This Article

ÇELİK, M., ÇAVUŞ, S. A., ABDULLEYAVA, M. (2022). Nasopharyngeal Carriage and Serotype Distribution of Streptococcus pneumoniae in Elderly: A Cross-sectional Study in Turkey. Infectious diseases and clinical microbiology (Online), Cilt: 4 - Sayı: 2, 99–106. https://ajindex.com/articles/539061

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. 1 Jansen AGSC, Rodenburg GD, Van Ende A Der, van Alphen L, Veenhoven RH, Spanjaard L, et al. Invasive pneumococcal disease among adults: Associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009;49(2):23-9. [CrossRef] 2 Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network. Streptococcus pneumoniae, 2018 [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC). (May 22, 2020; cited January 26, 2022). Available from: https://www.cdc. gov/abcs/reports-findings/survreports/spneu18.html 3 Bizri AR, Althaqafi A, Kaabi N, Obeidat N, Al Akoury N, Haridy H. The Burden of invasive vaccine-preventable diseases in adults in the Middle East and North Africa (MENA) Region. Infect Dis Ther. 2021;10(2):663-85. [CrossRef] 4 Thomas RE. Pneumococcal pneumonia and invasive pneumococcal disease in those 65 and older: Rates of detection, risk factors, vaccine effectiveness, hospitalisation and mortality. Geriatr. 2021;6(1):1-17. [CrossRef] 5 Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: Burden of disease. Clin Microbiol Infect. 2014;20(S5):45- 51. [CrossRef] 6 Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144-54. [CrossRef] 7 Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38(5):632-9. [CrossRef] 8 Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study. Lancet Infect Dis. 2015;15(5):535-43. [CrossRef] 9 Rodrigo C, Bewick T, Sheppard C, Greenwood S, Mckeever TM, Trotter CL, et al. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. Eur Respir J. 2015;45(6):1632-41. [CrossRef] 10 Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: Updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32(1):165-79. [CrossRef] 11 [Vaccination Circular of Risk Groups]. [Internet]. Ankara:
  2. Ministry of Health, General Directorate of Public Health. (June 17, 2016; cited January 26,